ORKA

Oruka Therapeutics (ORKA)

About Oruka Therapeutics (ORKA)

Oruka Therapeutics, Inc. is a biotechnology company, which focuses on developing novel monoclonal antibody therapeutics for PsO and other I&I indications. Its pipeline includes ORKA-001 and ORKA-002. The company is headquartered in Menlo Park, CA.

Details

Daily high

$32.21

Daily low

$28.10

Price at open

$28.17

52 Week High

$32.28

52 Week Low

$5.48

Market cap

1.5B

Dividend yield

0.00%

Volume

4.8M

Avg. volume

673,024

P/E ratio

-13.17

Oruka Therapeutics News